Rchr
J-GLOBAL ID:201801002484535664
Update date: May. 24, 2024
Hamaguchi Shigeto
ハマグチ シゲト | Hamaguchi Shigeto
Affiliation and department:
Job title:
Associate Professor
Research field (1):
Infectious disease
Research theme for competitive and other funds (6):
Papers (107):
-
Daisuke Onozuka, Satoko Takatera, Hiroo Matsuo, Hisao Yoshida, Shigeto Hamaguchi, Shungo Yamamoto, Ryuichi Minoda Sada, Koichiro Suzuki, Keiji Konishi, Satoshi Kutsuna. Oral mouthwashes for asymptomatic to mildly symptomatic adults with COVID-19 and salivary viral load: a randomized, placebo-controlled, open-label clinical trial. BMC oral health. 2024. 24. 1. 491-491
-
Ryuichi Minoda Sada, Hiroo Matsuo, Daisuke Motooka, Satoshi Kutsuna, Shigeto Hamaguchi, Go Yamamoto, Akiko Ueda. Clostridium butyricum Bacteremia Associated with Probiotic Use, Japan. Emerging Infectious Diseases. 2024. 30. 4. 665-671
-
Ryuichi Minoda Sada, Hiroo Matsuo, Daisuke Motooka, Satoshi Kutsuna, Shigeto Hamaguchi, Go Yamamoto, Akiko Ueda. Clostridium butyricum Bacteremia Associated with Probiotic Use, Japan. Emerging infectious diseases. 2024. 30. 4. 665-671
-
Ayumi Morimura, Masateru Taniguchi, Hiroyasu Takei, Osamu Sakamoto, Norihiko Naono, Yukihiro Akeda, Daisuke Onozuka, Jumpei Yoshimura, Kazunori Tomono, Satoshi Kutsuna, et al. Using novel micropore technology combined with artificial intelligence to differentiate Staphylococcus aureus and Staphylococcus epidermidis. Scientific Reports. 2024. 14. 1
-
Keiji Konishi, Daisuke Onozuka, Satoko Takatera, Hiroo Matsuo, Hisao Yoshida, Shigeto Hamaguchi, Shungo Yamamoto, Ryuichi Minoda Sada, Koichiro Suzuki, Satoshi Kutsuna. Protocol for a Randomized, Open-Label Clinical Trial on the Effect of Mouthwash on Salivary SARS-CoV-2 Load. Life (Basel, Switzerland). 2023. 13. 12
more...
MISC (24):
-
野口貴弘, 橘敬祐, 井上豪, 阪井丘芳, 辻川和丈, 藤尾慈, 山岸義晃, 濱口重人, 忽那賢志, 近藤昌夫. Safety evaluation of innovative medical material Matching Transformation System (MA-T) in mice: histological analysis of organs. 日本薬学会年会要旨集(Web). 2023. 143rd
-
前田大槻, 鍵田正智, 鍵田正智, 吉岡範, 吉岡範, 出口松夫, 塚本寛子, 塚本寛子, 高尾美有紀, 高尾美有紀, et al. 新型コロナウイルス抗体定量試薬「Access SARS-CoV-2 IgG II」の性能評価. 医療検査と自動化(Web). 2021. 46. 4
-
高尾美有紀, 高尾美有紀, 鍵田正智, 鍵田正智, 吉岡範, 吉岡範, 出口松夫, 塚本寛子, 塚本寛子, 前田大槻, et al. 新型コロナウイルス抗体定量試薬「ADVIA Centaur SARS-CoV-2 IgG(sCOVG)」の性能評価. 医療検査と自動化(Web). 2021. 46. 4
-
吉岡範, 吉岡範, 出口松夫, 鍵田正智, 鍵田正智, 塚本寛子, 塚本寛子, 高尾美有紀, 高尾美有紀, 前田大槻, et al. 新型コロナウイルス感染症検査診断法の比較. 医療検査と自動化(Web). 2021. 46. 4
-
鍵田正智, 鍵田正智, 吉岡範, 吉岡範, 出口松夫, 塚本寛子, 塚本寛子, 高尾美有紀, 高尾美有紀, 前田大槻, et al. 富士レビオ社新型コロナウイルス抗体定量試薬「SARS-CoV-2 S-IgG(IB)」の性能評価. 医療検査と自動化(Web). 2021. 46. 4
more...
Return to Previous Page